METHODS. This retrospective, case-control, observational trial included 125 patients with RVO who underwent brain magnetic resonance imaging (MRI) and 1105 age-matched controls who underwent comprehensive medical interviews and MRI. Underlying cardiovascular diseases and MRI findings were investigated in the patients with RVO according to age (<60 or ‡60 years) and RVO occlusion level (central or branch). The characteristics of underlying cardiovascular disease and MRI findings were compared between the younger patients with RVO and age-matched controls. The cerebrovascular burden also was assessed in the younger patients with RVO.
R
etinal vein occlusion (RVO) is the second most common retinal vascular disease causing vision loss and affects approximately 16 million people worldwide. 1, 2 In populationbased studies, the incidence of RVO is greater than 48 per 100,000 person-years in the general population, and is higher in those aged 50 years or older. The incidence of RVO has increased exponentially with the increasing age of the population, and the health-related burden of the disease also has expanded. However, the incidence of RVO also is considerable in the younger population. 3, 4 Emerging evidence suggests that RVO is associated with subsequent cardiovascular disease, including stroke and myocardial infarction, and that hypertension, diabetes mellitus, hyperlipidemia, and cigarette smoking are risk factors.
2,4-8 RVO-related hemodynamic changes and thrombus formation result from compression of an adjacent retinal vein by a thickened retinal artery, that is, anatomically classified as a small artery to arteriole. Therefore, RVO is considered to be an arterial disease. 3, 4, 9 Although its layered anatomy and metabolic activity are a little different from those of the brain, the retina differentiates from the diencephalon during embryonic development, so it shares some physiologic characteristics with the brain. [10] [11] [12] [13] [14] [15] Interestingly, similar pathologic changes that occur with RVO also are manifested in the brain in the form of cerebral small vessel disease (SVD), including white matter hyperintensities (WMH), cerebral microbleeds (CMBs), and silent lacunar infarcts. In this study, we investigated the little known association between RVO and cerebral SVD using magnetic resonance imaging (MRI) of the brain and fundus photography.
METHODS
The study was approved by the institutional review boards at Seoul National University Bundang Hospital (approval number B-1506-304-114) and Seoul National University Hospital (SNUH) Healthcare System Gangnam Center (approval number J-1609-065-791), and was conducted in accordance with the tenets of the Declaration of Helsinki. We searched the RVO registry database at Seoul National University Bundang Hospital and identified 524 consecutive patients with an incidental finding of RVO (137 with central and 387 with branch RVO) between January 2009 and October 2014. Patients who had RVO combined with retinal artery occlusion (n ¼ 3), diabetic retinopathy (n ¼ 12), inflammatory retinal disease (n ¼ 5), or a pre-existing brain mass lesion (n ¼ 3) were excluded. No patient had other serious ocular disease or a hematologic or inflammatory etiology for RVO. We identified the patients who also had undergone brain MRI within 1 year on either side of the first presentation of incidental RVO. We also investigated the reason for brain MRI in these patients; brain MRI sometimes was ordered by the neurologists, but was performed mostly in the absence of neurologic symptoms as part of a health screening program. A total of 125 patients with incidental RVO and results for MRI of the brain could be included in the analysis. Figure 1 shows a flow chart of the subject selection process and final dataset available for analysis.
Demographics, Medical History, and Ophthalmic Evaluation
All patients underwent a complete ophthalmic examination at the initial visit, which included slit-lamp biomicroscopy, indirect ophthalmoscopy, fundus photography (Vx-10; Kowa Optimed, Tokyo, Japan; Optos PLC, Dunfermline, Scotland, UK), and fluorescein angiography (Vx-10, Kowa Optimed). We obtained demographic information and a medical history (e.g., hypertension, diabetes mellitus, dyslipidemia, smoking, and cardiovascular disease, including acute stroke, transient ischemic attack, atrial fibrillation, and valvular heart disease) by detailed review of all patients' medical charts to evaluate cardiovascular risk factors. We also reviewed laboratory test results (e.g., complete blood cell count, erythrocyte sedimentation rate, C-reactive protein, and blood coagulation test) in all patients to identify a specific cause for RVO. We then subcategorized the patients according to age (<60 or ‡60 years). The prevalence of cerebral SVD is different between older and younger age groups. Several well-known populationbased studies of cerebral SVD selected 60 years as a cutoff value for the elderly population. Accordingly, we chose 60 years as the cutoff value for our analysis of the relationship between RVO and cerebral SVD. [16] [17] [18] Further, we subcategorized the patients according to level of RVO (central or branch) and analyzed central RVO (CRVO) according to area of capillary nonperfusion (10 disc diopters on fluorescein angiography, ischemic or nonischemic) based on initial ophthalmic examination.
Age-Matched Controls for Young Patients With RVO
Age is a potent risk factor of cerebral SVD, and age-matched controls for old patients with RVO do not have clinical significance. To compare brain MRI findings between younger patients with RVO and the normal population, we retrospectively reviewed a consecutive series of 1110 neurologically healthy individuals (<60 years) who visited SNUH Healthcare System Gangnam Center for a routine health check between October 2003 and December 2004, and participated in the SNUH Gangnam Survey. 19, 20 We defined neurologically and ophthalmologically healthy individuals as those who had not experienced a stroke or transient ischemic attack, had no symptoms or signs of neurologic disease, had no decrease in best corrected visual acuity, and had no history of retinal disease. Five of these 1110 individuals had not undergone a brain MRI, so they were excluded, leaving 1105 asymptomatic individuals with brain MRI results and without overt neurologic or retinal disease for enrolment. Clinical information was obtained by personal interview, and each subject underwent a physical examination by a trained physician.
Evaluation of Brain MRI
We evaluated aging of the brain and the status of the vessels in patients with RVO using a 1.5 or 3.0 Tesla MRI scanner (Intera or Achieva; Philips, Best, The Netherlands; Signa; GE, Milwaukee, WI, USA). The 5 mm axial slices were obtained using conventional MR protocols: T1-weighted (repetition time [TR]/echo time [TE], 300/12), T2-weighted (TR/TE, 4800/100), and fluid attenuated inversion recovery (FLAIR) (TR/TE, 11,000/140) images. An additional special protocol, that is T2* gradient-recalled echo (GRE) images (TR/TE, 724/23), was used to assess CMBs, one of the MRI markers for SVD in the brain, and diffusion-weighted MRI (TR/TE, 4800/66) was performed to evaluate acute infarction. The large vessels of the brain were visualized on time-of-flight angiographic images with three-dimensional reconstruction on MRI (TR/TE, 20/7; thickness, 1.2 mm). WMHs, CMBs, silent lacunar infarctions composed of cerebral SVD, and acute cerebral infarcts were defined as focal high-signal lesions on diffusion-weighed MR images. 13, 21 WMHs were graded by the Fazekas score (0, absent; 1, caps and thin lining in the ventricle or scattered dot lesions in white matter; 2, smooth halo or early confluent lesions in deep white matter; 3, massive periventricular lesions extending to the deep white matter with a confluent shape). 22 CMBs were defined as round-shaped dark signals with a blooming artifact on T2*-GRE images and within 5 mm in diameter. 23, 24 Silent lacunar infarction was detected as a hyperintense signal on T2-weighted or FLAIR images and hypointensity on T2-weighted images with a diameter between 3 mm and 2 cm. 25 As described in our previous study, cerebral SVD was deemed to be present if the brain had one of the following markers: a Fazekas score of 1 or more on WMHs, existence of CMB, or presence of silent lacunar infarction. 26 MR images for the control group were captured using a 1.5 Tesla Chorus MRI scanner (ISOL Technology, Inc., Kyungki-Do, Republic of Korea). No subject in this study had experienced acute ischemic stroke, so routine protocols were used in this survey except for the diffusion-weighted images. T1-weighted (TR/TE ¼ 520/12), T2-weighted (TR/TE ¼ 5800/96), FLAIR (TR/ TE ¼ 8500/96; inversion time ¼ 2100), and T2*-GRE (TR/TE ¼ 150/15; flip angle, 268) images were obtained. One set of images comprised 24 transaxial slices per scan without an interslice gap.
To ensure accurate judgments from subjective observations, one trained ophthalmologist (KHC) and one trained stroke neurologist (CKK), both blinded to the clinical information, assessed the degree of WMH, CMBs, and silent lacunar infarctions on brain MRI. Any disagreement was resolved by re-evaluation and discussion.
Statistical Analysis
Interobserver agreement for brain MRI between the two investigators (KHC, CKK) was excellent (Cohen's j ¼ 0.845). 27 The statistical analysis was performed using SPSS version 22.0 for Windows (IBM Corp., Armonk, NY, USA). P values < 0.05 were considered to be statistically significant.
RESULTS

Demographic and Clinical Characteristics
We included a total of 125 patients with RVO (57 men, 68 women), comprising 38 in the central RVO group and 87 in the branch RVO group. The mean age was 63.9 (range, 20-89 years) and 86 patients were older than 60 years at the time of their initial diagnosis. Hypertension was the most common underlying condition (72 patients, 58%), followed by dyslipidemia and diabetes mellitus. There was no difference in the prevalence of diabetes mellitus and dyslipidemia between the groups when categorized by age; however, patients younger than 60 years were more likely to smoke (P ¼ 0.001) and less likely to have hypertension (P ¼ 0.061) than their older counterparts. In addition, patients showed a similar incidence of previous cardiovascular diseases, including acute stroke, transient ischemic attack, ischemic heart disease, and valvular heart disease in the groups of age categorization (Table 1 ).
Brain MRI Findings According to Age in Patients With RVO
We evaluated the reasons for brain MRI in all subjects. Nine patients (7%) visited the emergency room with neurologic symptoms, 14 (11%) visited the outpatient clinic in our neurology department with neurologic symptoms, and the others (82%) underwent brain MRI in the absence of neurologic symptoms as part of a comprehensive health screening program. Therefore, most information was gathered incidentally. The overall prevalence rates of acute cerebral infarction (concurrent ischemic brain infarct) and cerebral SVD in the patients with RVO were 5% and 54%, respectively. Patients with RVO who were aged 60 years or older showed a similar prevalence of acute cerebral infarction (P ¼ 0.375), but their prevalence of cerebral SVD was significantly higher than that in patients younger than 60 years (62% [n ¼ 53] vs. 38% [n Table 2 ; Fig. 2 ) The younger patients with RVO (mean age, 50.5 6 9.4 years) had cardiovascular risk factors similar to those in the control group. However, the younger patients with RVO had a significantly higher overall prevalence of SVD (P 0.001), including significantly higher prevalence rates of WMH, CMBs, and silent lacunar infarcts (all P < 0.05; Table 3 ; Fig. 3 ).
Brain MRI Findings According to Anatomy in Patients With RVO
The frequencies of acute cerebral infarction and cerebral SVD were similar between the central and branch RVO groups (P ¼ 0.873 and P ¼ 0.654, respectively). Further, the distribution of subtypes of cerebral SVD, including WMH, CMB, and silent lacunar infarct, was not significantly different between the two groups (Supplementary Table S1 ). In addition, prevalence or distribution of subtypes of cerebral SVD was not significantly different between ischemic and nonischemic CRVO (Supplementary Table S2 ).
DISCUSSION
We evaluated fundus photography, fluorescein angiography, and brain MRI results in 125 patients with incidental RVO, and compared the findings of these investigations in young patients with RVO aged <60 years to those in an age-matched control population. Although concurrent stroke was relatively common (6 of 125 patients, 5%), more than half of the patients with incidental RVO presented with cerebral SVD, which increases the risk of future cognitive impairment, ischemic stroke, and even vascular death irrespective of cardiovascular disease. [28] [29] [30] [31] [32] In addition, when focusing on the younger patients with RVO, the burden of cerebral SVD was considerably large compared to that in the age-matched normal population.
Historically, cerebral SVD has been considered as a group of pathologic processes with various etiologies that affect the small arteries and arterioles of the brain. 21, 23 The retinal artery, blockage of which is assumed to be the fundamental cause of RVO, is a small artery to arteriole level vessel with the same embryologic origin as the brain arterioles. 12, 14, 33, 34 Because of this anatomic and embryologic relationship, cerebral SVD was found frequently in patients with RVO in the present study, and this was not surprising.
Cerebral SVD is known to be a marker of vascular ageing and accumulation of vascular risks, and the importance of early modification of risk factors, particularly hypertension, in patients with cerebral SVD currently is emerging. 21, 28, 31, 35 RVO also is known to be a vascular disease with similar vascular risks. 4, 36 Accordingly, the same disease developing in separate organs could indicate a shared disease mechanism and similar underlying risk factors for the disease. However, we must look at this problem from different angles when considering our results in young patients with RVO. When we compared our young patients with RVO with an agematched normal population with similar vascular risk factors, we found a large burden of cerebral SVD in the RVO group. This finding indicates that the relationship between RVO and SVD is not only as a marker of accumulated risk for vascular disease, but also a crucial indicator of vascular aging in individual patients. An ophthalmologic finding of RVO, especially at a relatively young age, could be an indicator of degeneration of brain vessels reflecting cerebrovascular age and not just chronologic age. 14, 30, 35 Several recently published population-based and clinical studies have shown a relationship between retinal vascular disease and acute cerebral stroke, and suggested a higher risk of stroke in young patients with RVO. 4, 29 Another report has proposed that cerebral aging seems accelerated by 10 to 20 years in young patients with stroke. 30 Furthermore, several studies have reported that cerebral SVD is associated with cognitive dysfunction and cerebrovascular accident. 28, 31, 35, 37 Although more data are needed to confirm if this is the case, when these reports are combined with our present results, it seems that RVO and cerebral SVD have a relationship with each other, and this relationship is intensified in young patients. We suggest that identification and treatment of RVO could be a gatekeeper to prevent future cognitive dysfunction and severe neurologic deficit in young patients. Given that RVO usually presents as acute vision loss that may prompt a clinic visit, the primary physician or ophthalmologist must counsel or refer for appropriate evaluation and risk modification.
There are some limitations to our study. First, we included only those patients with RVO whose brain MRI findings were available, which might be a source of selection bias. However, most brain MRI scans were incidentally performed in patients with RVO, which would minimize the likelihood of such bias. Second, there are no long-term follow-up data on the study patients, so we were not able to determine the incidence of SVD in patients with RVO. Unfortunately, we could not investigate the genetic background of patients with cerebral SVD and RVO in this study. Further evaluation is warranted in this respect. In conclusion, patients with RVO have a large burden of cerebral SVD, which is magnified in younger patients. We believe that RVO might be a surrogate marker for SVD, especially in the young age groups. Given that young patients with SVD and RVO could be at future risk of severe cerebrovascular disease and cognitive dysfunction, early modification of vascular risk factors may be needed. 
